R. Micheli

Neurological Adverse Events Associated with Immune Checkpoint Inhibitors: Diagnosis and Management

A. Hottinger, T. Hundsberger, Christophoros Astaras, 2018, Current Neurology and Neuroscience Reports.

Estrogenic Recruitment Followed by Chemotherapy in Breast Cancer: Experimental and Clinical Results

D. Amadori, P. Sismondi, A. Nicolin, 1987 .

Management of Primary CNS Lymphoma in Elderly Patients

A. Hottinger, F. Grandoni, R. Micheli, 2017 .

Dose optimization of MK-8628 (OTX015), a small molecule inhibitor of bromodomain and extra-terminal (BET) proteins, in patients (pts) with recurrent glioblastoma (GB).

M. Sanson, O. Chinot, A. Hottinger, 2016 .

Phase I/II study of S49076, a multi-target inhibitor of c-MET, AXL, FGFR in combination with bevacizumab in patients with recurrent glioblastoma.

K. Hoang-Xuan, P. Therasse, O. Chinot, 2016 .

Interactive process mining of cancer treatment sequences with melanoma real-world data

S. Pradervand, M. Cuendet, O. Michielin, 2023, Frontiers in Oncology.

Cytokinetic studies and treatment results of estrogens followed by chemotherapy in locally advanced (LABC) and metastatic (MBC) human breast cancer

D. Amadori, P. Sismondi, A. Nicolin, 1986 .